INCOMAT welcomes participation of scientists/engineers and institutions active in the fields of biomaterials for medical
applications who are located either in Europe or in the Western Balkan Countries and Newly Independent States
Specific Support Action
(SSA) INCOMAT
Basic Concept
Overall Objectives
One of the main tasks of INCOMAT
is to identify where biomedical
research could make a significant
impact on the quality of life of all
EUROPEAN citizens including
those of WBC and NIS. In this
context, the most important objective
of INCOMAT is to identify the
scientific areas where ‘cutting-edge”
developments could provide the
supportive technology platform for
innovative implants for hard tissue
applications
The structure of INCOMAT enables
the transfer of scientific knowledge
from Europe to the Western Balkan
Countries and Newly Independent
States. Concentrated research efforts
by the Teams of Excellence will
explore new concepts and support the
technological-reference basis of the
EU Environmental Technologies
Action Plan.
•
•
•
•
The homepage of INCOMAT can be found at:
to obtain a comprehensive
evaluation of the key
resources in biomaterials
research and industry in the
WBC and NIS
to act as an international
platform for the exchange of
good laboratory practices
and technological expertise
to identify cooperation
opportunities for joint
activities and future R&D
projectsthat address the
special needs of WBC and
NIS
to establish scientific and
technological exchange
activities like networking,
meetings, workshops and
biomaterial conferences
www.ssa-incomat.com
INCOMATwelcomes participation of scientists/engineers and institutions active in the fields of biomaterials for medical
applications who are located either in Europe of in theWestern Balkan Countries and Newly Independent States
Teams of Excellence
The biomedical aspects associated
with the INCOMAT project cover a
broad spectrum of subjects in the field
of biomaterials for hard tissue
applications. The consortium is
composed of Four Teams of
Excellence, each one chaired by a team
leader.
Team 1: Bone Tissue Engineering
Team leader: Dr. Serena Best
University of Cambridge, Department
of Materials Science and Metallurg,y
Cambridge, UK.
Team 3: In-vitro/in-vivo Testing for
Osteointegration
Team leader: Dr. Klaus Liefeith
Institute for Bioprocessing and
Analytical Measurement Techniques,
Heiligenstadt, D.
Team 2: Bioactive and Biomimetic
Coatings for Enhanced Bone
Interactions
Team leader: Dr. Maja Sikiric
Rudjer Boskovic Institute, Zagreb, HR.
Team 4: Quality Assurance and
Certification of MedicalProducts
Team leader: Dr. Ute Müller
BMP Labor für medizinische
Materialprüfung GmbH, Aachen, D.
INCOMAT: Contract Funded by the European Community (Project number: NMP3-CT-2007-032918;
from 01.03.2007 to 28.02.2009)
How to Contact INCOMAT:
The 15-partner Organizations:
Administrative coordinator:
Thüringen innovativ GmbH (D);
iba Heiligenstadt e.V. (D);
Rudjer Boskovic Institute (HR);
Serbian Academy of Science and Art (CS);
Scientific Technology Park Metolit (BY);
Georgian Technical University Centre for
Medical Polymers and Biomaterials (GE);
Paton Electric Welding - National Academy
of Science of Ukraine (UA);
Institute for Problems of Materials Science,
National Academy of Science of Ukraine
(UA);
Innovative Klebetechnik Zimmermann (D)
BMP Labor für medizinische Materialprüfung
GmbH (D);
Mrs. Elke Römhild
THÜRINGEN innovativ GmbH
Mainzerhofstrasse 10, 99084 Erfurt (D)
tel: +49 361 7892376
email: [email protected]
Scientific Coordinator:
Dr. Klaus Liefeith
iba Heiligenstadt e.V. Department of
Biomaterials
Rosenhof, 37308 Heilbad Heiligenstadt (D)
tel: +49 3606 671170
email: [email protected]
Institute of Nuclear Sciences VINCA
(CS);
Institute on Laser and Information
Technologies (RU);
University of Texas at San Antonio,
Dept. of Biomedical Engineering (US);
University of Cambridge, Dept. of
Materials Science and Metallurgy (UK);
Institute of Low Temperature Physics National Academy of Science of Ukraine
(UA).
INCOMAT aims at identify research and technology collaboration opportunities with Western
Balkan Countries (WBC) and Newly Independent States (NIS)
Your participation is welcome!
Financed by the European Community (Specific Support Action: 6. FP/Priority 3/NMP;
from 1 March 2007 to 28 February 2009)
INCOMAT aims at developing sustained collaborations in the field of biomedical research
among participants from WBC, NIC and members of the European Community.
Western Balkan Countries (WBC)
(Croatia, Serbia-Montenegro)
Newly Independent States (NIS)
(Ukraine, Belarus, Russia, Georgia)
INCOMAT Organisation and Structure
Please complete the electronic questionnaire at www.ssa-incomat.com
Regional Analysis in
Biomedical Research
(questionnaire)
Development of R&D Strategies
(based on regional strengths
and potential)
WBC and NIS
Croatia
Serbia-Montenegro
Belarus, Georgia,
Russia, Ukraine
Scientific/Administration
Coordinator
Four Teams of Excellence
International Biomaterials
Conference in Erfurt (D)
19.-20.02.2009
Dissemination
Applications
Technology Transfer
Proposals for continuing and
new research projects